vimarsana.com
Home
Live Updates
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript : vimarsana.com
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript
Operator: Good morning ladies and gentlemen and welcome to the Amicus Therapeutics' Full Year 2023 Financial Results Conference Call and Webcast.
Related Keywords
United States ,
Germany ,
United Kingdom ,
San Diego ,
California ,
Japan ,
Austria ,
Jeff Gatseli ,
Salveen Richter ,
Asia Pacific ,
Simon Harford ,
Bradley Campbell ,
Andrew Faughnan ,
Morgan Stanley ,
Anupam Rama ,
Ellen Rosenberg ,
Malcolm Kuno ,
Eliana Merle ,
Mitchell Goldman ,
Ellie Merle ,
Jeff Castelli ,
Joseph Schwartz ,
Sebastien Martel ,
Kristen Kluska ,
Goldman Sachs ,
Cantor Fitzgerald ,
Clinical Trial Program ,
Exchange Commission ,
Nasdaq ,
Development Officer ,
Amicus Therapeutics Inc ,
Amicus Therapeutics ,
Call Transcript February ,
Amicus Therapeutic Full Year ,
Results Conference Call ,
Vice President ,
Amicus Therapeutic ,
Chief Executive Officer ,
Chief Business Officer ,
Chief Financial Officer ,
Chief Development ,
Chief Medical Officer ,
Chief Legal ,
Private Securities Litigation Reform Act ,
Chief Executive ,
Thanks Andrew ,
Rare Disease Day ,
Disease Day ,
Middle East ,
Pompe Disease ,
Chief Development Officer ,
Amicus Pompe ,
Annual World Symposium ,
Treatment Award ,
Pompeii Phase ,
Thanks Simon ,
Buy According ,
Future Stocks For The Long ,
Ritu Baral ,
Clinical Trial ,
Jeff Hung ,
Unidentified Analyst ,
vimarsana.com © 2020. All Rights Reserved.